<?xml version='1.0' encoding='utf-8'?>
<document id="24687541"><sentence text="Chronic Digoxin Toxicity Precipitated by Dronedarone."><entity charOffset="41-52" id="DDI-PubMed.24687541.s1.e0" text="Dronedarone" /></sentence><sentence text="To report the case of a patient who presented with chronic symptoms attributable to dronedarone-induced digoxin toxicity"><entity charOffset="84-95" id="DDI-PubMed.24687541.s2.e0" text="dronedarone" /><entity charOffset="104-111" id="DDI-PubMed.24687541.s2.e1" text="digoxin" /><pair ddi="false" e1="DDI-PubMed.24687541.s2.e0" e2="DDI-PubMed.24687541.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24687541.s2.e0" e2="DDI-PubMed.24687541.s2.e1" /></sentence><sentence text=" A review of the literature is also provided" /><sentence text="" /><sentence text="This case report details a case of a 77-year-old male patient who presented to the hospital with multiple ambiguous symptoms that lasted several weeks" /><sentence text=" The patient was later hospitalized for symptoms of chronic digoxin toxicity, including prolonged nausea, diarrhea, weakness, and lack of appetite" /><sentence text=" The patient had a long history of digoxin use for control of his atrial fibrillation but experienced signs and symptoms of toxicity only after the addition of dronedarone"><entity charOffset="35-42" id="DDI-PubMed.24687541.s7.e0" text="digoxin" /><entity charOffset="160-171" id="DDI-PubMed.24687541.s7.e1" text="dronedarone" /><pair ddi="false" e1="DDI-PubMed.24687541.s7.e0" e2="DDI-PubMed.24687541.s7.e0" /><pair ddi="false" e1="DDI-PubMed.24687541.s7.e0" e2="DDI-PubMed.24687541.s7.e1" /></sentence><sentence text="" /><sentence text="Both the Naranjo and Drug Interaction Probability Scales indicated a &quot;probable&quot; relationship between the development of digoxin toxicity and dronedarone"><entity charOffset="120-127" id="DDI-PubMed.24687541.s9.e0" text="digoxin" /><entity charOffset="141-152" id="DDI-PubMed.24687541.s9.e1" text="dronedarone" /><pair ddi="false" e1="DDI-PubMed.24687541.s9.e0" e2="DDI-PubMed.24687541.s9.e0" /><pair ddi="false" e1="DDI-PubMed.24687541.s9.e0" e2="DDI-PubMed.24687541.s9.e1" /></sentence><sentence text=" Due to a p-glycoprotein-mediated interaction, dronedarone is able to decrease the renal clearance of digoxin, thus putting patients at risk for potentially fatal digoxin toxicity"><entity charOffset="47-58" id="DDI-PubMed.24687541.s10.e0" text="dronedarone" /><entity charOffset="102-109" id="DDI-PubMed.24687541.s10.e1" text="digoxin" /><entity charOffset="163-170" id="DDI-PubMed.24687541.s10.e2" text="digoxin" /><pair ddi="false" e1="DDI-PubMed.24687541.s10.e0" e2="DDI-PubMed.24687541.s10.e0" /><pair ddi="false" e1="DDI-PubMed.24687541.s10.e0" e2="DDI-PubMed.24687541.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24687541.s10.e0" e2="DDI-PubMed.24687541.s10.e2" /><pair ddi="false" e1="DDI-PubMed.24687541.s10.e1" e2="DDI-PubMed.24687541.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24687541.s10.e1" e2="DDI-PubMed.24687541.s10.e2" /></sentence><sentence text="" /><sentence text="This is the second case report detailing dronedarone-induced digoxin toxicity and the first to focus on chronic digoxin toxicity"><entity charOffset="41-52" id="DDI-PubMed.24687541.s12.e0" text="dronedarone" /><entity charOffset="61-68" id="DDI-PubMed.24687541.s12.e1" text="digoxin" /><entity charOffset="112-119" id="DDI-PubMed.24687541.s12.e2" text="digoxin" /><pair ddi="false" e1="DDI-PubMed.24687541.s12.e0" e2="DDI-PubMed.24687541.s12.e0" /><pair ddi="false" e1="DDI-PubMed.24687541.s12.e0" e2="DDI-PubMed.24687541.s12.e1" /><pair ddi="false" e1="DDI-PubMed.24687541.s12.e0" e2="DDI-PubMed.24687541.s12.e2" /><pair ddi="false" e1="DDI-PubMed.24687541.s12.e1" e2="DDI-PubMed.24687541.s12.e1" /><pair ddi="false" e1="DDI-PubMed.24687541.s12.e1" e2="DDI-PubMed.24687541.s12.e2" /></sentence><sentence text=" The presentation, possible causes, and drug-drug interactions associated with digoxin toxicity are described"><entity charOffset="79-86" id="DDI-PubMed.24687541.s13.e0" text="digoxin" /></sentence><sentence text=" This report aims to increase clinicians' awareness of this possible complication" /><sentence text=" It is recommended that digoxin be discontinued prior to initiating dronedarone"><entity charOffset="24-31" id="DDI-PubMed.24687541.s15.e0" text="digoxin" /><entity charOffset="68-79" id="DDI-PubMed.24687541.s15.e1" text="dronedarone" /><pair ddi="false" e1="DDI-PubMed.24687541.s15.e0" e2="DDI-PubMed.24687541.s15.e0" /><pair ddi="false" e1="DDI-PubMed.24687541.s15.e0" e2="DDI-PubMed.24687541.s15.e1" /></sentence><sentence text=" If concomitant therapy is absolutely necessary, the dose of digoxin should be halved prior to initiating dronedarone"><entity charOffset="61-68" id="DDI-PubMed.24687541.s16.e0" text="digoxin" /><entity charOffset="106-117" id="DDI-PubMed.24687541.s16.e1" text="dronedarone" /><pair ddi="false" e1="DDI-PubMed.24687541.s16.e0" e2="DDI-PubMed.24687541.s16.e0" /><pair ddi="false" e1="DDI-PubMed.24687541.s16.e0" e2="DDI-PubMed.24687541.s16.e1" /></sentence><sentence text=" Digoxin plasma levels should be monitored closely, with frequent patient evaluation for signs and symptoms of digoxin toxicity"><entity charOffset="1-8" id="DDI-PubMed.24687541.s17.e0" text="Digoxin" /><entity charOffset="111-118" id="DDI-PubMed.24687541.s17.e1" text="digoxin" /><pair ddi="false" e1="DDI-PubMed.24687541.s17.e0" e2="DDI-PubMed.24687541.s17.e0" /><pair ddi="false" e1="DDI-PubMed.24687541.s17.e0" e2="DDI-PubMed.24687541.s17.e1" /></sentence><sentence text="" /></document>